Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib-a differentiated ...

Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertise ...

Panelists discuss how the future treatment landscape for myeloproliferative neoplasms is evolving with many promising ...

Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

A panelist explains how the distinct mechanisms of erythropoiesis-stimulating agents (ESAs), luspatercept, and imetelstat ...

Discover 10 effective natural remedies for dry cough that actually work. Simple ingredients from your kitchen can provide ...

Panelists discuss how exciting ongoing research efforts are expanding similar gene therapy technologies to other muscular dystrophies like FSHD and myotonic dystrophy, using strategies to knock down ...

Patients with severe alcoholic hepatitis appear more likely to have small intestinal bacterial overgrowth compared with ...

The review introduces the molecular subtypes of breast cancer and outlines how altered amino acid metabolism supports tumor ...

Coherent Corp. (NYSE:COHR) is one of the best NYSE stocks to buy for long term investment. On June 24, Coherent announced the ...

The procedure, known as therapeutic apheresis, filters blood through a specialized machine. It removes abnormal proteins, ...

Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side effects. One promising solution involves cytokines, natural proteins that ...